Brent Allen Hanks

机构：University of North Carolina at Chapel Hill, University of North Carolina Health Care, Molecular Oncology (United States), UNC Lineberger Comprehensive Cancer Center · ORCID：0000-0002-2803-3272

发表论文 169 篇 · 总被引 4109 次 · h-index 31

代表论文

• Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors (2025 · Journal for ImmunoTherapy of Cancer · 被引 13)
• GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling (2025 · Cancer Research · 被引 10)
• Tumor-derived Extracellular Vesicles Induce ER Stress to Drive Tolerogenic Dendritic Cell Development in the Tumor Microenvironment (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
• Unlocking the Therapeutic Potential of the cGAS–STING Pathway through TREX1 Targeting (2025 · Cancer Research · 被引 1)
• Data from GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling (2025 · 被引 1)
• Abstract A097: Analyzing immunotherapy resistance in microsatellite instable colorectal FFPE samples using RNA sequencing (2025 · Cancer Immunology Research · 被引 1)